Glaucoma drainage devices in Boston keratprosthesis type 1 patients:Ahmed glaucoma valve versus baerveldt glaucoma valve

Paper Presentation | Présentation d'article
3:50 PM, Sunday 27 Jun 2021 (5 minutes)

Authors: Joseph R. Hakim1, Dominique Geoffrion2, Mona Harissi-Dagher3.

1Universtié de Montréal, 2McGill University, 3Université de Montréal.

Disclosure Block:

J.R. Hakim: None. D. Geoffrion: None. M. Harissi-Dagher: None.

Abstract Body:

Purpose: To compare the long-term outcomes of glaucoma drainage devices (GDD) in Boston keratoprosthesis type 1 (KPro) patients, specifically those of the Ahmed glaucoma valve (AGV) versus those of the Baerveldt glaucoma implant (BGI).
Study Design: Retrospective cohort study.
Methods: Retrospective cohort study of 44 eyes (44 patients) implanted with a KPro between 2008 and 2017. KPro eyes with AGV (n=35) were compared to those with BGI (n=9) in the main cohort. A sub-cohort comparing KPro eyes with AGV installed pre-KPro (n=9) to those with BGI installed pre-KPro (n=7) was further examined. The primary outcome was GDD failure, defined by uncontrolled intraocular pressure, additional glaucoma surgery or tube removal. Secondary outcomes included GDD related complications, change in best-corrected visual acuity (BCVA), intraocular pressure (IOP) and number of glaucoma medications. Differences in outcomes were compared using parametric and non-parametric tests, as well as Kaplan-Meier survival log-rank test to compare failure over time.
Results: Mean age was 60.0±15.4 years at KPro surgery and mean follow-up time was 5.4 ±2.3 years. In the main cohort, KPro eyes with AGV had a higher cumulative failure probability over time compared to that of eyes with BGI (57.1% versus 11.1%; P=0.039). More eyes with AGV required additional glaucoma surgery procedures compared to eyes with BGI (37.1% vs. 11.1%; P=0.135). The occurrence of GDD-related complications was similar between AGV and BGI (37.1% vs 33.3%, P=0.832). Regarding BCVA, there was an improvement in 55.6% of eyes with BGI compared to 42.9% of AGV eyes (P=0.71.) Change in IOP and number of topical glaucoma medications was also comparable in both groups (P>0.05) over the follow-up period. In the subcohort, outcomes between GDDs implanted before KPro surgery were concordant with those of the main cohort.
Conclusions: Compared to AGV, BGI implanted in KPro eyes was associated with lower GDD failure rates and slightly higher occurrence of improved BCVA while having a comparable occurrence of long-term complications.

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.